CERENO SCIENTIFIC AB
Cereno Scientific AB develops a new innovative treatment for patients with increased risk of blood clotting, based on the company's newly patented research findings. Cereno Scientific AB develops drugs that normalize the body's own defense system against blood clots for the treatment of complications in cardiovascular diseases.
CERENO SCIENTIFIC AB
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2012-01-01
Address:
Mölndal, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.cerenoscientific.se
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
ADn'tox
Adn'tox develops innovative tools for genotoxicology.
Current Employees Featured
Investors List
GU Ventures
GU Ventures investment in Seed Round - Cereno Scientific AB
Official Site Inspections
http://www.cerenoscientific.se
- Host name: 185-26-49-38.fi-hel1.upcloud.host
- IP address: 185.26.49.38
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "Cereno Scientific AB"
Cereno Scientific
Nov 29, 2024 Cereno has a project portfolio targeting diseases with high unmet medical needs. The aim is to develop treatments that can enhance and extend the lives of affected patients. …See details»
Read more about Cereno's organization | Corporate governance
Sep 14, 2023 Extraordinary General Meeting September 2020. The extraordinary General Meeting of Cereno Scientific AB (Publ) took place at University of Gothenburg's premises at …See details»
Cereno Scientific is a leading clinical stage biotech company
Cereno Scientific is a pioneering clinical-stage biotech company developing innovative treatments to enhance and extend the lives of patients with diseases that have high unmet medical needs.See details»
Cereno Scientific är ett ledande biotechbolag | Om oss
Född 1959. Sten R. Sörensen har en omfattande erfarenhet inom läkemedels-, biotech och finansindustrin. Han har tidigare bland annat varit chef för den internationella …See details»
Investors - Cereno Scientific
Cereno Scientific is a pioneering clinical-stage biotech company focusing on developing innovative, effective, and safe treatments for patients affected by diseases with high unmet …See details»
Cereno Scientific - LinkedIn
Cereno Scientific is a clinical stage biotech company within cardiovascular diseases. The lead drug candidate, CS1, is a Phase II candidate in development for the treatment of the rare …See details»
Cereno Scientific AB - Crunchbase Company Profile
Jul 1, 2018 Cereno Scientific AB develops a new innovative treatment for patients with increased risk of blood clotting. View contacts for Cereno Scientific AB to access new leads and connect with decision-makers.See details»
Cereno Scientific reports insider share purchases | Placera
Nov 29, 2024 E-post: [email protected]. Telefon: +46 704 92 35 63 . Sten R. Sörensen, CEO. Email: [email protected]. Phone: +46 73-374 03 74 . …See details»
Cereno Scientific - placera.se
Nov 28, 2024 Email: [email protected]. Phone: +46 708-14 31 75 . Sten R. Sörensen, CEO. Email: [email protected]. Phone: +46 73-374 03 74 . …See details»
Cereno Scientific - Craft
Cereno Scientific has 5 employees at their 1 location. See insights on Cereno Scientific including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Annual report 2020 - Cereno Scientific
Cereno Scientific is a biotech company focusing on developing innovative treatments for patients afected by common and rare cardiovascular diseases. Cardiovascular disease is the number 1 …See details»
Cereno Scientific - YouTube
Cereno Scientific is a Swedish-based clinical-stage biotech company in cardiovascular disease. The company focuses on developing innovative treatments for patients affected by common …See details»
Edison Investment Research publishes an updated research note …
Nov 28, 2024 Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary …See details»
Cereno Scientific - PitchBook
Cereno Scientific General Information Description. Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation …See details»
Cereno Scientific AB ® | Cereno Scientific
Cereno Scientific is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi).See details»
Pressmeddelanden - Cereno Scientific
Nov 28, 2024 Pressmeddelanden. Läs alla våra regulatoriska och icke-regulatoriska nyheter om företagetSee details»
Press - Cereno Scientific
Nov 26, 2024 Press Archive. Read all our regulatory and non-regulatory news about the companySee details»
Cereno Scientific reports insider share purchases | Placera
3 days ago E-post: [email protected]. Telefon: +46 704 92 35 63 . Sten R. Sörensen, CEO. Email: [email protected]. Phone: +46 73-374 03 74 . …See details»
Newsroom - Cereno Scientific
Nov 20, 2024 LSX Nordic Congress 2019 Contact Sten R. Sörensen on +46 (0) 733 74 03 74 or [email protected] to schedule a meeting. Read more... Read more. 04 Feb …See details»
Cereno Scientific reports insider share purchases - Cision News
3 days ago Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary …See details»